Herbal Medicine in the Treatment of Ulcerative Colitis

被引:110
作者
Ke, Fei [2 ]
Yadav, Praveen Kumar [1 ]
Ju, Liu Zhan [1 ]
机构
[1] Tongji Univ, Shanghai Peoples Hosp 10, Dept Gastroenterol, Shanghai 200072, Peoples R China
[2] Tongji Univ, Shanghai Peoples Hosp 10, Dept Surg, Shanghai 200072, Peoples R China
基金
中国国家自然科学基金;
关键词
Herbal medicine; inflammatory bowel disease; therapy; ulcerative colitis; INFLAMMATORY-BOWEL-DISEASE; GERMINATED BARLEY FOODSTUFF; INTESTINAL EPITHELIAL-CELLS; FACTOR-KAPPA-B; DOUBLE-BLIND; COMPLEMENTARY THERAPIES; BOSWELLIA-SERRATA; SODIUM-BUTYRATE; DIETARY FIBER; MURINE MODEL;
D O I
10.4103/1319-3767.91726
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Ulcerative colitis (UC) is a refractory, chronic, and nonspecific disease occurred usually in the rectum and the entire colon. The etiopathology is probably related to dysregulation of the mucosal immune response toward the resident bacterial flora together with genetic and environmental factors. Several types of medications are used to control the inflammation or reduce symptoms. Herbal medicine includes a wide range of practices and therapies outside the realms of conventional Western medicine. However, there are limited controlled evidences indicating the efficacy of traditional Chinese medicines, such as aloe vera gel, wheat grass juice, Boswellia serrata, and bovine colostrum enemas in the treatment of UC. Although herbal medicines are not devoid of risk, they could still be safer than synthetic drugs. The potential benefits of herbal medicine could lie in their high acceptance by patients, efficacy, relative safety, and relatively low cost. Patients worldwide seem to have adopted herbal medicine in a major way, and the efficacy of herbal medicine has been tested in hundreds of clinical trials in the management of UC. The evidences on herbal medicine are incomplete, complex, and confusing, and certainly associated with both risks and benefits. There is a need for further controlled clinical trials of the potential efficacy of herbal medicine approaches in the treatment of UC, together with enhanced legislation to maximize their quality and safety.
引用
收藏
页码:3 / 10
页数:8
相关论文
共 67 条
  • [51] Rectal gel application of Withania somnifera root extract expounds anti-inflammatory and muco-restorative activity in TNBS-induced Inflammatory Bowel Disease
    Pawar, Pankaj
    Gilda, Suhit
    Sharma, Siddhesh
    Jagtap, Suresh
    Paradkar, Anant
    Mahadik, Kakasaheb
    Ranjekar, Prabhakar
    Harsulkar, Abhay
    [J]. BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2011, 11
  • [52] MECHANISMS OF DISEASE Inflammatory Bowel Disease
    Abraham, Clara
    Cho, Judy H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (21) : 2066 - 2078
  • [53] Immunomodulatory role of Withania somnifera root powder on experimental induced inflammation:: An in vivo and in vitro study
    Rasool, M.
    Varalakshmi, P.
    [J]. VASCULAR PHARMACOLOGY, 2006, 44 (06) : 406 - 410
  • [54] Sartor RB, 2009, NESTLE NUTR WORKS SE, V64, P121, DOI 10.1159/000235787
  • [55] Butyrate inhibits inflammatory responses through NFκB inhibition:: implications for Crohn's disease
    Segain, JP
    de la Blétière, DR
    Bourreille, A
    Leray, V
    Gervois, N
    Rosales, C
    Ferrier, L
    Bonnet, C
    Blottière, HM
    Galmiche, JP
    [J]. GUT, 2000, 47 (03) : 397 - 403
  • [56] Patient nonadherence to medication in inflammatory bowel disease
    Sewitch, MJ
    Abrahamowicz, M
    Barkun, A
    Bitton, A
    Wild, GE
    Cohen, A
    Dobkin, PL
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (07) : 1535 - 1544
  • [57] Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease
    Shale, MJ
    Riley, SA
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (02) : 191 - 198
  • [58] In vivo measurement of colonic butyrate metabolism in patients with quiescent ulcerative colitis
    Simpson, EJ
    Chapman, MAS
    Dawson, J
    Berry, D
    Macdonald, IA
    Cole, A
    [J]. GUT, 2000, 46 (01) : 73 - 77
  • [59] Estrogen-like activity of licorice root constituents: glabridin and glabrene, in vascular tissues in vitro and in vivo
    Somjen, D
    Knoll, E
    Vaya, J
    Stern, N
    Tamir, S
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2004, 91 (03) : 147 - 155
  • [60] Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1β, and nuclear factor κB in trinitrobenzene sulphonic acid induced colitis in rats
    Song, M
    Xia, B
    Li, J
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2006, 82 (964) : 130 - 135